Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Towards optimal collaboration: reforming the WHO country cooperation strategy in Thailand.

Tiantong S, Limwattanayingyong A, Wibulpolprasert S, Vedrasco L, Kertesz D.

Bull World Health Organ. 2019 Sep 1;97(9):642-644. doi: 10.2471/BLT.18.219287. Epub 2019 Jul 4. No abstract available.

2.

Isolated vocal akathisia-Does it exist?

Kertesz DP, Maze D.

Asian J Psychiatr. 2018 Aug;36:64-65. doi: 10.1016/j.ajp.2018.06.015. Epub 2018 Jun 28.

PMID:
29966890
3.

Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study.

Kertesz DP, Swartz MV, Tadger S, Plopski I, Barak Y.

Clin Neuropharmacol. 2015 Jan-Feb;38(1):23-5. doi: 10.1097/WNF.0000000000000061.

PMID:
25580924
4.

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.

WHO Ebola Response Team, Aylward B, Barboza P, Bawo L, Bertherat E, Bilivogui P, Blake I, Brennan R, Briand S, Chakauya JM, Chitala K, Conteh RM, Cori A, Croisier A, Dangou JM, Diallo B, Donnelly CA, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fuhrer C, Fukuda K, Garske T, Gasasira A, Gbanyan S, Graaff P, Heleze E, Jambai A, Jombart T, Kasolo F, Kadiobo AM, Keita S, Kertesz D, Koné M, Lane C, Markoff J, Massaquoi M, Mills H, Mulba JM, Musa E, Myhre J, Nasidi A, Nilles E, Nouvellet P, Nshimirimana D, Nuttall I, Nyenswah T, Olu O, Pendergast S, Perea W, Polonsky J, Riley S, Ronveaux O, Sakoba K, Santhana Gopala Krishnan R, Senga M, Shuaib F, Van Kerkhove MD, Vaz R, Wijekoon Kannangarage N, Yoti Z.

N Engl J Med. 2014 Oct 16;371(16):1481-95. doi: 10.1056/NEJMoa1411100. Epub 2014 Sep 22.

5.

Headache treatment after electroconvulsive treatment: a single-blinded trial comparator between eletriptan and paracetamol.

Kertesz DP, Trabekin O, Vanetik MS.

J ECT. 2015 Jun;31(2):105-9. doi: 10.1097/YCT.0000000000000179.

PMID:
25181019
6.

Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses.

Tang G, Kertesz DJ, Yang M, Lin X, Wang Z, Li W, Qiu Z, Chen J, Mei J, Chen L, Mirzadegan T, Harris SF, Villaseñor AG, Fretland J, Fitch WL, Hang JQ, Heilek G, Klumpp K.

Bioorg Med Chem Lett. 2010 Oct 15;20(20):6020-3. doi: 10.1016/j.bmcl.2010.08.068. Epub 2010 Aug 19.

PMID:
20829038
7.

Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-benzyl derivatives with broad potency against resistant mutant viruses.

Kertesz DJ, Brotherton-Pleiss C, Yang M, Wang Z, Lin X, Qiu Z, Hirschfeld DR, Gleason S, Mirzadegan T, Dunten PW, Harris SF, Villaseñor AG, Hang JQ, Heilek GM, Klumpp K.

Bioorg Med Chem Lett. 2010 Jul 15;20(14):4215-8. doi: 10.1016/j.bmcl.2010.05.040. Epub 2010 May 16.

PMID:
20538456
8.

Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Sweeney ZK, Dunn JP, Li Y, Heilek G, Dunten P, Elworthy TR, Han X, Harris SF, Hirschfeld DR, Hogg JH, Huber W, Kaiser AC, Kertesz DJ, Kim W, Mirzadegan T, Roepel MG, Saito YD, Silva TM, Swallow S, Tracy JL, Villasenor A, Vora H, Zhou AS, Klumpp K.

Bioorg Med Chem Lett. 2008 Aug 1;18(15):4352-4. doi: 10.1016/j.bmcl.2008.06.072. Epub 2008 Jun 28.

PMID:
18632268
9.

Dietary supplement use is prevalent among children with a chronic illness.

Ball SD, Kertesz D, Moyer-Mileur LJ.

J Am Diet Assoc. 2005 Jan;105(1):78-84.

PMID:
15635350
10.

Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimization.

Elworthy TR, Kertesz DJ, Kim W, Roepel MG, Quattrocchio-Setti L, Smith DB, Tracy JL, Chow A, Li F, Brill ER, Lach LK, McGee D, Yang DS, Chiou SS.

Bioorg Med Chem Lett. 2004 Apr 5;14(7):1655-9.

PMID:
15026044
11.

Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.

Kertesz DA, Touré K, Berthé A, Konaté Y, Bougoudogo F.

J Infect Dis. 2003 May 15;187 Suppl 1:S69-73.

PMID:
12721894
12.

Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists.

Bryan SA, Jose PJ, Topping JR, Wilhelm R, Soderberg C, Kertesz D, Barnes PJ, Williams TJ, Hansel TT, Sabroe I.

Am J Respir Crit Care Med. 2002 Jun 15;165(12):1602-9.

PMID:
12070060
13.

Cruise ships: high-risk passengers and the global spread of new influenza viruses.

Miller JM, Tam TW, Maloney S, Fukuda K, Cox N, Hockin J, Kertesz D, Klimov A, Cetron M.

Clin Infect Dis. 2000 Aug;31(2):433-8. Epub 2000 Sep 7.

PMID:
10987701
14.

Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators.

Tyrrell GJ, Senzilet LD, Spika JS, Kertesz DA, Alagaratnam M, Lovgren M, Talbot JA.

J Infect Dis. 2000 Jul;182(1):168-73. Epub 2000 Jun 29.

PMID:
10882594
15.

Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group.

Deeks SL, Palacio R, Ruvinsky R, Kertesz DA, Hortal M, Rossi A, Spika JS, Di Fabio JL.

Pediatrics. 1999 Feb;103(2):409-13.

PMID:
9925833
16.

[Pneumococcal infection and anti-pneumococcal vaccination programs in Canada].

Spika JS, Kertesz D, Deeks S, Talbot J.

Presse Med. 1998 May;27 Suppl 1:39-42. French. No abstract available.

PMID:
9779040
17.

Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance Study.

Kertesz DA, Di Fabio JL, de Cunto Brandileone MC, Castañeda E, Echániz-Aviles G, Heitmann I, Homma A, Hortal M, Lovgren M, Ruvinsky RO, Talbot JA, Weekes J, Spika JS.

Clin Infect Dis. 1998 Jun;26(6):1355-61.

PMID:
9636862
18.

Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada.

Kertesz DA, Coulthart MB, Ryan JA, Johnson WM, Ashton FE.

J Infect Dis. 1998 Jun;177(6):1754-7.

PMID:
9607865
19.

Influenza A outbreak on a cruise ship.

Miller J, Tam T, Afif C, Maloney S, Cetron M, Fukata K, Klimov A, Hall H, Kertesz D, Hockin J.

Can Commun Dis Rep. 1998 Jan 15;24(2):9-11. English, French. No abstract available.

20.

Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group.

Weinstein MR, Litt M, Kertesz DA, Wyper P, Rose D, Coulter M, McGeer A, Facklam R, Ostach C, Willey BM, Borczyk A, Low DE.

N Engl J Med. 1997 Aug 28;337(9):589-94.

21.

Surveillance of invasive meningococcal disease in Canada, 1995-1996.

Deeks S, Kertesz D, Ryan A, Johnson W, Ashton F.

Can Commun Dis Rep. 1997 Aug 15;23(16):121-5. English, French. No abstract available.

22.

Surveillance for Streptococcus pneumoniae in Latin American children.

Kertesz DA, Spika JS, Talbot JA, Difabio JL.

Can J Infect Dis. 1996 Jan;7(1):21-3. No abstract available.

23.

Selective inhibition of mammalian lanosterol 14 alpha-demethylase by RS-21607 in vitro and in vivo.

Swinney DC, So OY, Watson DM, Berry PW, Webb AS, Kertesz DJ, Shelton EJ, Burton PM, Walker KA.

Biochemistry. 1994 Apr 19;33(15):4702-13.

PMID:
8161528
24.
25.

Selective inhibition of mammalian lanosterol 14 alpha-demethylase: a possible strategy for cholesterol lowering.

Walker KA, Kertesz DJ, Rotstein DM, Swinney DC, Berry PW, So OY, Webb AS, Watson DM, Mak AY, Burton PM, et al.

J Med Chem. 1993 Jul 23;36(15):2235-7. No abstract available.

PMID:
8340925
26.

Infected pressure and diabetic ulcers.

Kertesz D, Chow AW.

Clin Geriatr Med. 1992 Nov;8(4):835-52. Review.

PMID:
1423138
27.

Stereoisomers of ketoconazole: preparation and biological activity.

Rotstein DM, Kertesz DJ, Walker KA, Swinney DC.

J Med Chem. 1992 Jul 24;35(15):2818-25.

PMID:
1495014
28.

Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.

Ong JT, Poulsen BJ, Akers WA, Scholtz JR, Genter FC, Kertesz DJ.

Arch Dermatol. 1989 Dec;125(12):1662-5.

PMID:
2589861
29.

[Treatment of complex fractures of the middle third of the face].

Kertesz D.

Odontoestomatologia. 1989 Oct;2(2):13-25. Spanish. No abstract available.

PMID:
2639684
30.

[Prophylaxis and treatment of infectious endocarditis].

Kertesz D.

Odontol Postgrado. 1989 Jul;2(3-4):21-3. Spanish. No abstract available.

PMID:
2638731
31.

Platelet aggregation inhibitory activity and vasodepressor activity of a series of bicyclo[3.2.0]hept-6-ylidene iminoxy alkanoic acids with modified lower side chains.

O-Yang C, Wu HY, Kertesz DJ, Kluge AF, Wallach MB, Willis AL, Smith DL, Chang LF.

Prostaglandins. 1987 Oct;34(4):519-34.

PMID:
3432556
32.

Orally active prostacyclin-mimetic RS-93427: therapeutic potential in vascular occlusive disease associated with atherosclerosis.

Willis AL, Smith DL, Vigo C, Kluge A, O'Yang C, Kertesz D, Wu H.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:254-65.

PMID:
2959059
33.

[The role of the conjunctival approach in the management of orbital blowout fractures].

Kertész D, Rodriguez FF.

Fogorv Sz. 1986 Mar;79(3):65-70. Hungarian. No abstract available.

PMID:
3456905
34.

[Deformities of the middle third of the face. Presentation of a case].

Kertesz D, Meneses Almelda D, Farfán González G.

Rev Cubana Estomatol. 1985 May-Aug;22(2):138-44. Spanish. No abstract available.

PMID:
3915565
35.

[Mentoplasty as adjunctive treatment of mandibular prognathism].

Farfán González G, Meneses Almeida D, Kertesz D.

Rev Cubana Estomatol. 1985 May-Aug;22(2):145-52. Spanish. No abstract available.

PMID:
3869989
36.

[Surgical treatment of saddle-back nose using autogenous bone graft].

Kertesz D, Felipe F, Vega R.

Rev Cubana Estomatol. 1984 Sep-Dec;21(3):315-25. Spanish. No abstract available.

PMID:
6399589
37.

Synthesis and platelet aggregation inhibition activity of a series of enantiomeric bicyclo[3.2.0]heptane-6-oximinoacetic acids (1).

O-Yang C, Kertesz DJ, Kluge AF, Kuenzler P, Li TT, Marx MM, Bruno JJ, Chang LF.

Prostaglandins. 1984 Jun;27(6):851-63.

PMID:
6484210
38.

[Treatment of orbital floor fractures through the conjunctival access].

Kertész D, Felipe Rodriguez F.

Rev Cubana Estomatol. 1982 May-Aug;19(2):76-89. Spanish. No abstract available.

PMID:
6963681
39.

Kinetics of reconstitutioin of polyphenoloxidase from apoenzyme and copper.

Kertesz D, Rotilio G, Brunori M, Zito R, Antonini E.

Biochem Biophys Res Commun. 1972 Dec 4;49(5):1208-15. No abstract available.

PMID:
4345671
40.

[Modern society and up-to-date health care].

Veress S, Vajda P, Kertész D, Bugovits E, Szíl K.

Orv Hetil. 1972 Dec 3;113(49):2982-9. Hungarian. No abstract available.

PMID:
4655764
41.

Effect of lithium on aggression. Mania- and permselective membranes.

Kertesz D, de Körösy F.

Experientia. 1972 Nov 15;28(11):1338. No abstract available.

PMID:
4674130
42.

Transient kinetic studies of DOPA oxidation by polyphenoloxidase.

Kertesz D, Brunori M, Zito R, Antonini E.

Biochim Biophys Acta. 1971 Nov 13;250(2):306-10. No abstract available.

PMID:
5004064
43.

The reduction of ferricytochrome c during the enzymic oxidation of 3,4-dihydroxyphenylalanine.

Kertesz D.

Biochim Biophys Acta. 1968 Oct 8;167(2):250-6. No abstract available.

PMID:
4978054
44.

[The peroxidase from fig latex. I. Purification and properties].

El-Fekih M, Kertesz D.

Bull Soc Chim Biol (Paris). 1968;50(3):547-68. French. No abstract available.

PMID:
5668590
45.

Studies on the equilibria and kinetics of the reactions of peroxidases with ligands. I. The reaction of ferroperoxidases with carbon monoxide.

Kertesz D, Antonini E, Brunori M, Wyman J, Zito R.

Biochemistry. 1965 Dec;4(12):2672-6. No abstract available.

PMID:
5880674
46.

Kinetic studies of the polyphenoloxidase action; kinetics in the presence of reducing agents.

KERTESZ D, ZITO R.

Biochim Biophys Acta. 1962 Oct 8;64:153-67. No abstract available.

PMID:
14032117
47.

[Indirect oxidation of reducing substances by polyphenoloxidase; oxidation of hydroquinone and monohydroxyphenols].

KERTESZ D, AZZOPARDI O.

Biochim Biophys Acta. 1962 Oct 8;64:149-52. French. No abstract available.

PMID:
14032116
48.

The indirect oxidation of reduced cytochrome c by polyphenol oxidase.

KERTESZ D, ZITO R.

Biochim Biophys Acta. 1962 Jun 4;59:752-4. No abstract available.

PMID:
14455371
49.
50.

[On the hydroxylation of monophenols in the presence of reducing agents and polyphenoloxidase].

KERTESZ D, AZZOPARDI O.

C R Seances Soc Biol Fil. 1960;154:81-4. French. No abstract available.

PMID:
14408656

Supplemental Content

Loading ...
Support Center